Mersana Therapeutics buy Guggenheim
Start price
14.08.25
/
50%
€0.26
Target price
14.08.26
€25.61
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 14.08.26. The prediction end date can be changed by Guggenheim at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Mersana Therapeutics | - | - |
| iShares Core DAX® | 3.002% | 4.755% |
| iShares Nasdaq 100 | 2.966% | 0.363% |
| iShares Nikkei 225® | 5.606% | 4.528% |
| iShares S&P 500 | 2.312% | 1.811% |
Comments by Guggenheim for this prediction
In the thread Mersana Therapeutics diskutieren
Mersana Therapeutics, Inc. (NASDAQ: MRSN) had its price target lowered by analysts at Guggenheim from $125.00 to $30.00. They now have a "buy" rating on the stock.
Ratings data for MRSN provided by MarketBeat
Stopped prediction by Guggenheim for Mersana Therapeutics
Mersana Therapeutics
Start price
Target price
Perf. (%)
€0.31
16.05.25
16.05.25
€4.46
16.05.26
16.05.26
-14.13%
25.07.25
25.07.25
